Besins Healthcare has an ongoing commitment to ensuring that the content on this website is accessible to the widest range of visitors, regardless of ability.
You can vary the text size by using your browser’s text resize option: in many web browsers this can be accessed by selecting View? Text Size or by pressing Ctrl + and Ctrl – on your keyboard.
Alternative text for images
All appropriate images have been given alternative text.
Heading elements
HTML heading elements have been used to represent page structure, supporting assistive technologies that allow page navigation from heading to heading.
Link text
All hyperlinks should make sense when read out of context, and hyperlinks are clearly presented in a different text style from normal body text.
JavaScript independence
Where JavaScript or other scripts are used for navigation or functionality, an alternative mechanism has been put in place in case your browser does not support these scripts.
Colour contrast
We have checked text and background colour combinations to ensure that the contrast is sufficient and we have also ensured that information is not referenced by colour alone.
Style sheets
We have used Cascading Style Sheets (CSS) to control the presentation of pages and have used properly structured markup for content. If style sheets are not supported or are turned off, information on the site can still be accessed and read.
Imvaggis is indicated for the local treatment of vaginal symptoms of oestrogen deficiency in postmenopausal women11
An ultra-low dose, estriol pessary that is easily inserted without the need for an applicator, designed with the patient in mind11, 12
Imvaggis significantly improves the symptoms of vaginal atrophy vs placebo at 12 weeks (p<0.001)13
The estriol (active ingredient) in Imvaggis is body identical, it is derived from yams and soya and is chemically identical to estriol produced naturally by the body 2, 11, 14
Imvaggis aligns with recommendations to use the lowest effective dose for treatment of vaginal atrophy15
